Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 35 | 2024 | 13262 | 2.370 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 13 | 2023 | 1728 | 1.890 |
Why?
|
Small Cell Lung Carcinoma | 9 | 2024 | 421 | 1.650 |
Why?
|
ras Proteins | 5 | 2016 | 1052 | 1.380 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2023 | 5251 | 1.320 |
Why?
|
Spheroids, Cellular | 6 | 2023 | 329 | 1.180 |
Why?
|
Cell Line, Tumor | 46 | 2024 | 16939 | 1.080 |
Why?
|
Exodeoxyribonucleases | 2 | 2024 | 195 | 1.050 |
Why?
|
Protein Kinase Inhibitors | 17 | 2023 | 5643 | 1.010 |
Why?
|
Membrane Proteins | 6 | 2024 | 7850 | 0.950 |
Why?
|
Benzamides | 7 | 2018 | 1369 | 0.920 |
Why?
|
Signal Transduction | 21 | 2024 | 23376 | 0.900 |
Why?
|
Killer Cells, Natural | 6 | 2024 | 2203 | 0.890 |
Why?
|
Interferons | 5 | 2024 | 705 | 0.860 |
Why?
|
Nucleotides, Cyclic | 2 | 2020 | 84 | 0.830 |
Why?
|
Drug Resistance, Neoplasm | 17 | 2024 | 5253 | 0.750 |
Why?
|
Neoplasms | 25 | 2024 | 22072 | 0.740 |
Why?
|
Phosphoproteins | 4 | 2024 | 2440 | 0.730 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3610 | 0.730 |
Why?
|
Pyrimidines | 8 | 2018 | 3016 | 0.650 |
Why?
|
Endogenous Retroviruses | 2 | 2021 | 111 | 0.620 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1229 | 0.610 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 286 | 0.560 |
Why?
|
Platinum | 1 | 2018 | 223 | 0.560 |
Why?
|
Mutation | 26 | 2024 | 29932 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2022 | 567 | 0.520 |
Why?
|
Adenocarcinoma | 5 | 2024 | 6315 | 0.520 |
Why?
|
Pyrimidinones | 1 | 2018 | 384 | 0.520 |
Why?
|
Immunity, Innate | 5 | 2024 | 3047 | 0.510 |
Why?
|
Retinoblastoma Protein | 9 | 2019 | 670 | 0.500 |
Why?
|
Janus Kinase 3 | 1 | 2015 | 77 | 0.500 |
Why?
|
Antineoplastic Agents | 11 | 2021 | 13630 | 0.490 |
Why?
|
Mice | 46 | 2024 | 81208 | 0.490 |
Why?
|
Tumor Microenvironment | 11 | 2024 | 3844 | 0.480 |
Why?
|
Genes, ras | 3 | 2022 | 655 | 0.480 |
Why?
|
Gene Deletion | 4 | 2020 | 2668 | 0.480 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.480 |
Why?
|
Molecular Targeted Therapy | 5 | 2021 | 2803 | 0.470 |
Why?
|
Autophagy | 3 | 2016 | 1337 | 0.440 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1454 | 0.440 |
Why?
|
Doxycycline | 1 | 2015 | 341 | 0.440 |
Why?
|
Immunotherapy | 8 | 2023 | 4642 | 0.440 |
Why?
|
Animals | 56 | 2024 | 167963 | 0.440 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2024 | 8515 | 0.430 |
Why?
|
I-kappa B Kinase | 4 | 2019 | 251 | 0.430 |
Why?
|
Autocrine Communication | 1 | 2014 | 169 | 0.430 |
Why?
|
Pyridones | 1 | 2018 | 792 | 0.430 |
Why?
|
MAP Kinase Kinase 1 | 4 | 2020 | 331 | 0.420 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2020 | 11712 | 0.390 |
Why?
|
Cell Survival | 5 | 2020 | 5797 | 0.380 |
Why?
|
Neovascularization, Pathologic | 2 | 2022 | 2640 | 0.370 |
Why?
|
Endothelial Cells | 4 | 2024 | 3539 | 0.360 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2017 | 2053 | 0.350 |
Why?
|
Chemokine CCL5 | 3 | 2016 | 215 | 0.350 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2018 | 346 | 0.340 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2009 | 68 | 0.340 |
Why?
|
Melanoma | 5 | 2023 | 5697 | 0.340 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.340 |
Why?
|
Humans | 103 | 2024 | 760621 | 0.330 |
Why?
|
Cell Nucleus | 6 | 2005 | 2907 | 0.320 |
Why?
|
Pancreatitis | 1 | 2016 | 1100 | 0.320 |
Why?
|
Microvessels | 2 | 2024 | 572 | 0.320 |
Why?
|
Cytokines | 8 | 2023 | 7343 | 0.320 |
Why?
|
Carcinoma, Renal Cell | 2 | 2024 | 3218 | 0.320 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4312 | 0.290 |
Why?
|
MicroRNAs | 2 | 2021 | 3790 | 0.290 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4490 | 0.280 |
Why?
|
Microfluidics | 2 | 2022 | 652 | 0.270 |
Why?
|
Drug Design | 3 | 2021 | 1061 | 0.260 |
Why?
|
Receptors, CCR2 | 2 | 2024 | 215 | 0.260 |
Why?
|
Interleukin-6 | 4 | 2017 | 3215 | 0.260 |
Why?
|
Mastocytosis, Systemic | 1 | 2006 | 102 | 0.240 |
Why?
|
Pyrazoles | 1 | 2015 | 1999 | 0.230 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 6131 | 0.230 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2024 | 94 | 0.230 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2018 | 556 | 0.230 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2919 | 0.230 |
Why?
|
RNA Interference | 4 | 2018 | 2846 | 0.230 |
Why?
|
NF-kappa B | 3 | 2023 | 2488 | 0.230 |
Why?
|
Enzyme Activation | 4 | 2016 | 3602 | 0.230 |
Why?
|
Carbonic Anhydrases | 1 | 2024 | 109 | 0.220 |
Why?
|
Janus Kinases | 3 | 2023 | 250 | 0.220 |
Why?
|
Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2802 | 0.210 |
Why?
|
Pyridines | 1 | 2015 | 2879 | 0.210 |
Why?
|
T-Lymphocytes | 7 | 2024 | 10181 | 0.210 |
Why?
|
Gastroenteritis | 1 | 2004 | 237 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2024 | 3584 | 0.210 |
Why?
|
Adrenergic Agents | 1 | 2022 | 74 | 0.200 |
Why?
|
Cell Culture Techniques | 3 | 2019 | 1664 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2023 | 4550 | 0.200 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 161 | 0.190 |
Why?
|
Receptor, Notch2 | 1 | 2021 | 87 | 0.190 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 158 | 0.190 |
Why?
|
Inflammation | 3 | 2020 | 10756 | 0.180 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2018 | 1765 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2024 | 2828 | 0.180 |
Why?
|
Mesothelioma | 2 | 2016 | 807 | 0.180 |
Why?
|
Eosinophilia | 1 | 2004 | 559 | 0.170 |
Why?
|
Gene Amplification | 2 | 2022 | 1085 | 0.170 |
Why?
|
Interferon Regulatory Factor-3 | 2 | 2018 | 141 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 286 | 0.170 |
Why?
|
Coculture Techniques | 2 | 2020 | 1342 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 362 | 0.160 |
Why?
|
Ligands | 3 | 2022 | 3276 | 0.160 |
Why?
|
Immunity | 3 | 2022 | 998 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
Up-Regulation | 3 | 2024 | 4122 | 0.160 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2018 | 41 | 0.160 |
Why?
|
Transcription Factors | 7 | 2023 | 12103 | 0.160 |
Why?
|
Receptor, Notch1 | 1 | 2021 | 495 | 0.160 |
Why?
|
Epigenomics | 1 | 2024 | 936 | 0.160 |
Why?
|
Ligases | 1 | 2020 | 332 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2895 | 0.160 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 56 | 0.160 |
Why?
|
Janus Kinase 1 | 1 | 2018 | 107 | 0.150 |
Why?
|
Cell Cycle | 3 | 2004 | 2934 | 0.150 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 307 | 0.150 |
Why?
|
p120 GTPase Activating Protein | 1 | 2018 | 36 | 0.150 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2022 | 432 | 0.150 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.150 |
Why?
|
Apoptosis | 7 | 2023 | 9501 | 0.150 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8986 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 251 | 0.150 |
Why?
|
Flow Cytometry | 3 | 2017 | 5870 | 0.150 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2018 | 600 | 0.150 |
Why?
|
Genomics | 6 | 2023 | 5794 | 0.140 |
Why?
|
Hydroxamic Acids | 2 | 2017 | 482 | 0.140 |
Why?
|
STAT1 Transcription Factor | 1 | 2018 | 333 | 0.140 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2018 | 1724 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7408 | 0.140 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 193 | 0.140 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 605 | 0.140 |
Why?
|
Telomerase | 1 | 2021 | 746 | 0.130 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4902 | 0.130 |
Why?
|
Mice, Nude | 2 | 2023 | 3607 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 786 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 717 | 0.130 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2015 | 30 | 0.130 |
Why?
|
Oxo-Acid-Lyases | 1 | 2015 | 22 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 370 | 0.130 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1046 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 642 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1894 | 0.130 |
Why?
|
Pancreatic Neoplasms | 3 | 2018 | 5351 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1055 | 0.130 |
Why?
|
Leukemia, Hairy Cell | 1 | 2015 | 82 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2014 | 17 | 0.120 |
Why?
|
High-Throughput Screening Assays | 2 | 2018 | 944 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18137 | 0.120 |
Why?
|
RNA, Double-Stranded | 3 | 2021 | 295 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 542 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2017 | 772 | 0.120 |
Why?
|
Monocytes | 1 | 2024 | 2575 | 0.120 |
Why?
|
Neovascularization, Physiologic | 1 | 2022 | 1336 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2019 | 4264 | 0.120 |
Why?
|
Point Mutation | 1 | 2020 | 1594 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1252 | 0.120 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 266 | 0.110 |
Why?
|
raf Kinases | 1 | 2014 | 118 | 0.110 |
Why?
|
RNA Splice Sites | 1 | 2015 | 211 | 0.110 |
Why?
|
Drug Resistance | 1 | 2020 | 1617 | 0.110 |
Why?
|
Off-Label Use | 1 | 2015 | 184 | 0.110 |
Why?
|
Gene Expression Profiling | 6 | 2019 | 9411 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 256 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2448 | 0.110 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 393 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 211 | 0.110 |
Why?
|
I-kappa B Proteins | 1 | 2014 | 212 | 0.110 |
Why?
|
NIH 3T3 Cells | 3 | 2018 | 670 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 995 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.110 |
Why?
|
Diplopia | 1 | 2014 | 215 | 0.100 |
Why?
|
Hemianopsia | 1 | 2014 | 121 | 0.100 |
Why?
|
Protein Kinases | 1 | 2020 | 1612 | 0.100 |
Why?
|
Immunophenotyping | 1 | 2017 | 1871 | 0.100 |
Why?
|
Tamoxifen | 1 | 2017 | 963 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2864 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5799 | 0.100 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2013 | 315 | 0.100 |
Why?
|
Cell Proliferation | 8 | 2020 | 10446 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2648 | 0.100 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2004 | 2159 | 0.100 |
Why?
|
Gait Disorders, Neurologic | 1 | 2014 | 238 | 0.100 |
Why?
|
Testicular Hormones | 2 | 2003 | 188 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1895 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 609 | 0.100 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2014 | 301 | 0.100 |
Why?
|
Breast Neoplasms | 6 | 2023 | 21025 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 806 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1648 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2018 | 3602 | 0.090 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2020 | 1693 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 1928 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2023 | 2873 | 0.090 |
Why?
|
DNA Replication | 3 | 2004 | 1412 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1889 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2023 | 9530 | 0.090 |
Why?
|
Molecular Dynamics Simulation | 1 | 2013 | 435 | 0.090 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4625 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.090 |
Why?
|
DNA | 1 | 2004 | 7233 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11345 | 0.080 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2023 | 376 | 0.080 |
Why?
|
Ovarian Neoplasms | 3 | 2024 | 4878 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1832 | 0.080 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2554 | 0.080 |
Why?
|
Genes, Lethal | 1 | 2009 | 225 | 0.080 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12626 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1347 | 0.080 |
Why?
|
Nuclear Proteins | 5 | 2023 | 5791 | 0.080 |
Why?
|
Male | 19 | 2024 | 359744 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1588 | 0.080 |
Why?
|
Female | 26 | 2024 | 391270 | 0.080 |
Why?
|
Fibroblasts | 4 | 2021 | 4090 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1008 | 0.080 |
Why?
|
Antigen Presentation | 2 | 2023 | 1254 | 0.080 |
Why?
|
bcl-X Protein | 1 | 2009 | 413 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3726 | 0.070 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 1035 | 0.070 |
Why?
|
S Phase | 3 | 2004 | 422 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2299 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3484 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58995 | 0.070 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2014 | 656 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2017 | 1088 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5496 | 0.070 |
Why?
|
Oncogenes | 2 | 2010 | 1220 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4713 | 0.070 |
Why?
|
Cell Cycle Proteins | 4 | 2020 | 3446 | 0.070 |
Why?
|
Cell Nucleolus | 2 | 2004 | 156 | 0.070 |
Why?
|
Histone Deacetylases | 3 | 2017 | 718 | 0.070 |
Why?
|
Lamin Type A | 2 | 2004 | 187 | 0.060 |
Why?
|
Organoids | 2 | 2023 | 729 | 0.060 |
Why?
|
DEAD-box RNA Helicases | 2 | 2023 | 383 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7269 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22023 | 0.060 |
Why?
|
Middle Aged | 10 | 2021 | 220352 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3618 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1837 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2018 | 3442 | 0.060 |
Why?
|
Glycoproteins | 2 | 2003 | 2208 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9276 | 0.060 |
Why?
|
Cell Lineage | 2 | 2024 | 2533 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11071 | 0.060 |
Why?
|
Prognosis | 3 | 2023 | 29658 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3600 | 0.060 |
Why?
|
DNA Polymerase III | 1 | 2004 | 51 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4775 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 42 | 0.050 |
Why?
|
Antibodies, Antinuclear | 1 | 2004 | 344 | 0.050 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2004 | 283 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2020 | 14372 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 161 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 106 | 0.050 |
Why?
|
Piperazines | 2 | 2019 | 2525 | 0.050 |
Why?
|
Proteomics | 3 | 2023 | 3817 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 468 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 727 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2014 | 3486 | 0.050 |
Why?
|
Proteins | 3 | 2003 | 6029 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2014 | 2566 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7588 | 0.050 |
Why?
|
Immunoblotting | 2 | 2017 | 1649 | 0.050 |
Why?
|
Laparotomy | 1 | 2004 | 465 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2003 | 306 | 0.050 |
Why?
|
Chemokine CXCL10 | 1 | 2023 | 316 | 0.050 |
Why?
|
Histones | 2 | 2004 | 2583 | 0.050 |
Why?
|
Cysteine Endopeptidases | 1 | 2004 | 548 | 0.050 |
Why?
|
Rubidium | 1 | 2000 | 122 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 698 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 9073 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41335 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 666 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 1484 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15789 | 0.050 |
Why?
|
Cell Differentiation | 4 | 2024 | 11481 | 0.050 |
Why?
|
Interphase | 1 | 2001 | 228 | 0.050 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2000 | 110 | 0.040 |
Why?
|
History, 21st Century | 1 | 2006 | 1575 | 0.040 |
Why?
|
Cyclin E | 1 | 2000 | 155 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2023 | 1351 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1565 | 0.040 |
Why?
|
Protein Binding | 3 | 2021 | 9335 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 878 | 0.040 |
Why?
|
Cell Count | 1 | 2004 | 1835 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 323 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2019 | 1115 | 0.040 |
Why?
|
Growth Inhibitors | 1 | 2000 | 378 | 0.040 |
Why?
|
Mast Cells | 1 | 2006 | 1390 | 0.040 |
Why?
|
Aged | 7 | 2021 | 169152 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3224 | 0.040 |
Why?
|
Virus Internalization | 1 | 2023 | 494 | 0.040 |
Why?
|
Transfection | 3 | 2021 | 5781 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2014 | 1982 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 514 | 0.040 |
Why?
|
Genome, Human | 3 | 2021 | 4417 | 0.040 |
Why?
|
Luciferases, Firefly | 1 | 2018 | 37 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 635 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2023 | 1067 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12965 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6465 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2005 | 1147 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2773 | 0.040 |
Why?
|
Intestine, Small | 1 | 2004 | 1207 | 0.040 |
Why?
|
Alleles | 1 | 2009 | 6898 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 67 | 0.040 |
Why?
|
Introns | 1 | 2021 | 978 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 503 | 0.040 |
Why?
|
Cell Division | 2 | 2003 | 4463 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9185 | 0.040 |
Why?
|
Cell Line | 5 | 2004 | 15620 | 0.040 |
Why?
|
Phosphorylation | 2 | 2019 | 8313 | 0.040 |
Why?
|
Drug Discovery | 2 | 2020 | 1057 | 0.040 |
Why?
|
Binding Sites | 3 | 2014 | 6048 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 854 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2024 | 1354 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1602 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 65017 | 0.030 |
Why?
|
Phthalazines | 1 | 2019 | 383 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1407 | 0.030 |
Why?
|
Cisplatin | 1 | 2023 | 1644 | 0.030 |
Why?
|
HeLa Cells | 2 | 2020 | 3105 | 0.030 |
Why?
|
Ovary | 1 | 2000 | 958 | 0.030 |
Why?
|
Genome | 2 | 2017 | 1739 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 373 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 1998 | 0.030 |
Why?
|
Acetoacetates | 1 | 2015 | 19 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 877 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1959 | 0.030 |
Why?
|
Antibodies | 1 | 2024 | 2421 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1613 | 0.030 |
Why?
|
Butyrates | 1 | 1996 | 169 | 0.030 |
Why?
|
Serine | 1 | 2019 | 830 | 0.030 |
Why?
|
Albumins | 1 | 2018 | 575 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2004 | 2145 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 13451 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1612 | 0.030 |
Why?
|
Computational Biology | 2 | 2019 | 3505 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2627 | 0.030 |
Why?
|
Chromatin | 2 | 2004 | 2938 | 0.030 |
Why?
|
Quinolines | 1 | 2020 | 759 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1356 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3157 | 0.030 |
Why?
|
Retinoblastoma-Like Protein p107 | 2 | 2004 | 71 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2018 | 2262 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2058 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2418 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2018 | 873 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1411 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 13981 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7593 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 1993 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1754 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 877 | 0.030 |
Why?
|
Retinoblastoma-Like Protein p130 | 2 | 2003 | 73 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3484 | 0.030 |
Why?
|
Laparoscopy | 1 | 2004 | 2147 | 0.030 |
Why?
|
Cell Movement | 1 | 2024 | 5206 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 203 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20509 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2981 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2913 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1110 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 897 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17624 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3758 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3361 | 0.020 |
Why?
|
3T3 Cells | 2 | 2004 | 1085 | 0.020 |
Why?
|
Paclitaxel | 1 | 2018 | 1736 | 0.020 |
Why?
|
Breast | 1 | 2019 | 1963 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 2019 | 1152 | 0.020 |
Why?
|
Models, Genetic | 1 | 2020 | 3442 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4373 | 0.020 |
Why?
|
Metabolome | 1 | 2017 | 982 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1737 | 0.020 |
Why?
|
Nervous System Neoplasms | 1 | 2010 | 91 | 0.020 |
Why?
|
Base Sequence | 1 | 2021 | 12446 | 0.020 |
Why?
|
Anti-Mullerian Hormone | 2 | 2003 | 407 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6216 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5434 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 11903 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 101 | 0.020 |
Why?
|
Fatty Acids | 1 | 2017 | 1804 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3084 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1529 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2021 | 18957 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3775 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2852 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3663 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 730 | 0.020 |
Why?
|
Phenotype | 2 | 2022 | 16546 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4000 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 983 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4938 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6068 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1738 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4573 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17790 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2014 | 1596 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3800 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 895 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2008 | 680 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 2013 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2882 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9585 | 0.010 |
Why?
|
Adult | 3 | 2021 | 219994 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20080 | 0.010 |
Why?
|
Mullerian Ducts | 1 | 2003 | 201 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2004 | 435 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 869 | 0.010 |
Why?
|
COS Cells | 1 | 2003 | 1129 | 0.010 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2001 | 20 | 0.010 |
Why?
|
E2F4 Transcription Factor | 1 | 2001 | 32 | 0.010 |
Why?
|
Retinoblastoma-Binding Protein 1 | 1 | 2001 | 138 | 0.010 |
Why?
|
Transcription Factor DP1 | 1 | 2001 | 136 | 0.010 |
Why?
|
Lamins | 1 | 2000 | 37 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8803 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13502 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2001 | 327 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2001 | 269 | 0.010 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2001 | 114 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2000 | 183 | 0.010 |
Why?
|
Culture Techniques | 1 | 2000 | 530 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2003 | 582 | 0.010 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2000 | 232 | 0.010 |
Why?
|
G1 Phase | 1 | 2000 | 403 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 1433 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2004 | 1313 | 0.010 |
Why?
|
Butyric Acid | 1 | 1996 | 51 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39261 | 0.010 |
Why?
|
Antigens, Viral, Tumor | 1 | 1996 | 153 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5039 | 0.010 |
Why?
|
Blood Proteins | 1 | 2000 | 1173 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58741 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 2506 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54303 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2000 | 2651 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3735 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2003 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74359 | 0.010 |
Why?
|
Telomere | 1 | 1996 | 933 | 0.010 |
Why?
|
Rats | 1 | 2003 | 23711 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9467 | 0.000 |
Why?
|